10 Stocks Expected To Post Impressive Earnings This Week

8. Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson is a healthcare company that designs, sells, researches, and manufactures different products globally. By net income, it is among the top 50 companies in the world. The firm has reported a very stable gross and operating margin over the last decade, which makes it a favorite among defensive investors.

JNJ is scheduled to release its Q4 earnings on Wednesday. The company’s estimated sales growth for Q4 is 5% YoY. Management expects a 5% to 7% revenue growth rate till FY 2030. EPS is projected to go up by 3.47% per year till FY 2033 as per the management, though this is only a conservative estimate.

The stock performance was dismal in the previous year registering an 8% decline. There are reasons to believe that the underperformance will reverse in 2025. For instance, the company books much of its R&D expenses in the last quarter of the year, so a relatively poor performance in this quarter wouldn’t necessarily reflect on the upcoming quarters.

The company has an attractive dividend yield of 3.41%. At an attractive valuation, the stock continues to be appealing for defensive investors.